Article Text
Editorial
Ideal therapy for secondary mitral regurgitation: should we look under the annulus?
Statistics from Altmetric.com
Footnotes
Contributors All authors contributed to initial draft and final editing of this article.
Funding This study was funded by the National Institute of Health/NHLBI.
Competing interests JH is on SAB of Chordalign. JSG is consultant for Edwards Lifesciences. GA is consultant for Abbott, Edwards Lifesciences, Medtronic and Cephea.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
- Valvular heart disease